Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi Archives of Clinical Pathology
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Hussein Albarazanchi Author
Subjects of specialization
Affiliation
Tamoxifen , , scientific
Kurdistan Institute for Strategic Studies and Scientific Research-Cancer, Iraq
Biography
Kurdistan Institute for Strategic Studies and Scientific Research-Cancer, Iraq
Publications
Short Communication Open Access
Correction of a scientific error in lippincott illustrated reviews pharmacology (anticancer drugs, p 605, Mechanism of action of tamoxifen)
Author(s): Hussein Albarazanchi
Tamoxifen is one of the selective estrogen receptor modulators (SERM) with tissue-precise activities for the treatment and prevention of estrogen receptor high-quality breast cancer. Tamoxifen acts as an anti-estrogen (inhibiting agent) in the mammary tissue, however as an estrogen (stimulating agent) in ldl cholesterol metabolism, bone density, and cell proliferation within the endometrium.
... view more»Google Scholars / Researchers Sites
